XLO Xilio Therapeutics, Inc.

NASDAQ
$9.04

Xilio Therapeutics, Inc. (XLO) is expected to report earnings on November 11, 2026, before the market open.

Xilio Therapeutics Reported Earnings
Wednesday, August 12, 2026 · 7:30 AM ET
Earnings Date
Nov 11
Wednesday · 7:30 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Xilio Therapeutics, Inc.

Xilio Therapeutics is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.